Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
-
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
-
Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in May
-
Magenta Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Magenta Therapeutics (MGTA) Prices 7.5M Share Common Offering at $8/Sh
-
Magenta Therapeutics Announces Pricing of Public Offering
-
Magenta Therapeutics (MGTA) Announces Proposed $60M Share Offering
-
Magenta Therapeutics Launches Proposed Public Offering
-
Magenta Therapeutics to Participate in Cowen Health Care Conference on Monday, March 2nd in Boston
-
Magenta Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Magenta Therapeutics (MGTA) Prices 4.25M Share Common Offering at $13.25/Sh
-
Magenta Therapeutics Announces Pricing of Public Offering
-
Magenta Therapeutics (MGTA) Book Building for May 2 Trading
-
Magenta Therapeutics (MGTA) to Offer 4.25M Shares
-
Magenta Therapeutics Launches Proposed Public Offering
-
Magenta Therapeutics to Present at Investor Conferences in March
-
Cowen Starts Magenta Therapeutics (MGTA) at Outperform
-
Magenta Therapeutics Announces Closing of Initial Public Offering
-
Magenta Therapeutics (MGTA) IPO Opens Modestly Higher

